< 1 minute read
Dec. 16, 2021

GSK852: a BET BD2 inhibitor

GSK852

1000x BD2-selective BET bromodomain inh. orally available in dog rational design from prior lead Journal of Medicinal Chemistry GlaxoSmithKline, Stevenage, UK

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in